OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00304256

Shandong Sino-Agri United Biotechnology Co Ltd

Agricultural ChemicalsVerified

Capital Structure and Liquidity Shandong Sino-Agri United Biotechnology Co Ltd has a debt-to-equity ratio of 1.09, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 0.56, suggesting limited short-term liquidity to cover immediate obligations. Free cash flow is negative at -67.4 million CNY, and operating cash flow is only 13.9 million CNY, indicating cash flow constraints. ### Profitability and Returns The company is currently unprofitable, with a net loss of 136.6 million CNY and an operating loss of 160.9 million CNY. Return on equity is -11.2%, and return on assets is -3.57%, both significantly below industry norms for Agricultural Chemicals, which typically show positive returns. These metrics suggest operational inefficiencies or cost overruns. ### Segments and Geographic Exposure The company operates in a single disclosed segment focused on pesticide production and sales. Revenue is primarily generated from domestic and international markets, though the exact geographic breakdown is not provided. The lack of segment granularity limits visibility into regional performance. ### Growth Trajectory The company's recent financial performance shows a decline in profitability, with a net loss and negative operating income. While revenue is reported at 1.86 billion CNY, the absence of historical revenue growth data and forward-looking guidance makes it difficult to assess future growth potential. ### Risk Factors The company faces liquidity risk due to a negative net cash position after subtracting total debt. The debt-to-equity ratio of 1.09 and negative free cash flow highlight financial stress. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. ### Recent Events No recent filings or transcripts are available in the provided data to indicate material changes in the company's operations or strategy. The absence of recent disclosures limits insight into management's response to current challenges.

30-day price · 003042-1.96 (-10.5%)
Low$16.04High$20.09Close$16.65As of15 May, 00:00 UTC
Profile
CompanyShandong Sino-Agri United Biotechnology Co Ltd
Ticker003042.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Shandong Sino-Agri United Biotechnology Co Ltd produces and sells pesticides, including imidacloprid, acetamiprid, nitenpyram, and pyridaben, primarily for agricultural use, with products distributed domestically and internationally.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a confidence level of 0.92.

### Capital Structure and Liquidity Shandong Sino-Agri United Biotechnology Co Ltd has a debt-to-equity ratio of 1.09, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 0.56, suggesting limited short-term liquidity to cover immediate obligations. Free cash flow is negative at -67.4 million CNY, and operating cash flow is only 13.9 million CNY, indicating cash flow constraints. ### Profitability and Returns The company is currently unprofitable, with a net loss of 136.6 million CNY and an operating loss of 160.9 million CNY. Return on equity is -11.2%, and return on assets is -3.57%, both significantly below industry norms for Agricultural Chemicals, which typically show positive returns. These metrics suggest operational inefficiencies or cost overruns. ### Segments and Geographic Exposure The company operates in a single disclosed segment focused on pesticide production and sales. Revenue is primarily generated from domestic and international markets, though the exact geographic breakdown is not provided. The lack of segment granularity limits visibility into regional performance. ### Growth Trajectory The company's recent financial performance shows a decline in profitability, with a net loss and negative operating income. While revenue is reported at 1.86 billion CNY, the absence of historical revenue growth data and forward-looking guidance makes it difficult to assess future growth potential. ### Risk Factors The company faces liquidity risk due to a negative net cash position after subtracting total debt. The debt-to-equity ratio of 1.09 and negative free cash flow highlight financial stress. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. ### Recent Events No recent filings or transcripts are available in the provided data to indicate material changes in the company's operations or strategy. The absence of recent disclosures limits insight into management's response to current challenges.
Key takeaways
  • The company is currently unprofitable with negative returns on equity and assets.
  • Liquidity is constrained, with a current ratio of 0.56 and negative free cash flow.
  • Debt levels are high, with a debt-to-equity ratio of 1.09.
  • Growth prospects are unclear due to a lack of historical revenue growth data and forward guidance.
  • The company operates in a single segment with limited geographic detail.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.86B
Gross profit$185.4M
Operating income-$161.0M
Net income-$136.6M
R&D
SG&A
D&A
SBC
Operating cash flow$13.9M
CapEx-$129.5M
Free cash flow-$67.4M
Total assets$3.82B
Total liabilities$2.60B
Total equity$1.22B
Cash & equivalents
Long-term debt$1.33B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.22B
Net cash-$1.33B
Current ratio0.6
Debt/Equity1.1
ROA-3.6%
ROE-11.2%
Cash conversion-10.0%
CapEx/Revenue-7.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric003042Activity
Op margin-8.6%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-7.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin10.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity109.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 06:31 UTC#a4f5cc88
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 12:19 UTCJob: f9008d33